In this video


Eli Lilly CEO: Looking for 'market based solutions' on drug costs

Medicare Part D is really the model going forward, says David Ricks, Eli Lilly CEO, talking about his meeting with President Trump and the pharma industry's move to provide competitive pricing on prescriptions. Also Ricks shares his thoughts on tax reform and the impact of regulations.
Wed, Feb 1 20177:17 AM EST